The reasons behind Big Data's rise

Share this article:

Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role.

Healthcare expenses are now 17.6% of GDP—nearly $600 billion more than the expected benchmark for a nation of the United States's size and wealth, notes the consultancy, which did a regression analysis of countries' income and spending data.

Payors are seeking to clamp costs by shifting from fee-for-service compensation to risk-sharing arrangements that prioritize outcomes, as well as partnering with pharma and basing reimbursement on drugs' ability to improve health. McKinsey also cites the move toward evidence-based medicine, with its reliance on aggregating individual data sets into big-data algorithms.

Healthcare could soon catch up to other sectors in using Big Data, as first movers in the data sphere are already achieving positive results.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters